|
Volumn 123, Issue 5, 2001, Pages 286-291
|
Adjuvant chemotherapy of cervical cancer - Results of a phase II-study;Die adjuvante chemotherapie des zervixkarzinoms - Ergebnisse einer phase II-studie
a a a a a a a |
Author keywords
Adjuvant chemotherapy; Anemia; Cervical cancer; Radiotherapy
|
Indexed keywords
AMIFOSTINE;
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
ERYTHROPOIETIN;
IFOSFAMIDE;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ALOPECIA;
ARTICLE;
BLOOD TOXICITY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER RISK;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
FEMALE;
HUMAN;
NEUROTOXICITY;
PHASE 2 CLINICAL TRIAL;
RADICAL HYSTERECTOMY;
UTERINE CERVIX CANCER;
ADENOCARCINOMA;
ADULT;
AGED;
AMIFOSTINE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, ADENOSQUAMOUS;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYSTERECTOMY;
IFOSFAMIDE;
MIDDLE AGED;
NEOPLASM STAGING;
RADIOTHERAPY, ADJUVANT;
UTERINE CERVICAL NEOPLASMS;
|
EID: 0034992370
PISSN: 00444197
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2001-14788 Document Type: Article |
Times cited : (8)
|
References (21)
|